How likely is a child with influenza to develop sudden brain swelling (influenza-associated encephalopathy or acute necrotizing encephalopathy)?
Evidence quality 4.13/5
Eight-dimension review score against the quality rubric . Each dimension scored 1–5.
- D1 Source grounding
- 5/5
- D2 Source authority
- 5/5
- D3 Arithmetic
- 3/5
- D4 Uncertainty
- 4/5
- D5 Scope
- 3/5
- D6 Prose
- 4/5
- D7 Perception honesty
- 4/5
- D8 Caveat completeness
- 5/5
● your factors — click this risk ▾ to reveal
- Your factors
≈ As likely as
Perceived
No survey measures how parents rate the odds that a child's flu turns into brain swelling. The condition entered wider awareness only after a cluster of pediatric deaths in January 2025 drew news coverage; before that most parents had never heard of influenza-associated encephalopathy. The intuitive read, when prompted, tends to split: either dismissed as something that does not happen to ordinary healthy children, or, after a news cycle about deaths in previously healthy kids, overweighted as a looming threat of any winter fever. Both readings sit far from a roughly 1-in-100,000-per-flu-episode base rate.
Rough estimate: Either near-zero (never heard of it) or, post-headline, inflated to the range of common flu complications
Source: editorial intuition, not polled
Actual
109 reported cases among an estimated ~11 million children with flu (~1 in 100,000)
US children aged <18 with influenza, 2024-25 season
Show derivation
Subgroup: a US child (<18) who contracts influenza; horizon: a single influenza episode, not an adult lifetime. Numerator: 109 IAE/ANE cases reported to CDC during the 2024-25 season (MMWR mm7436a1). Denominator: pediatric symptomatic flu illnesses. CDC estimated ~51 million symptomatic influenza illnesses across all ages for 2024-25 (range 43-73M). CDC did not publish a 2024-25 pediatric illness count; children aged <18 are ~22% of the US population but carry roughly twice the adult attack rate, so a conservative pediatric-illness floor of ~22% of 51M gives ~11.2M, while children's higher attack rate would push the true denominator higher (lowering the rate). Point: 109 / 11,000,000 = 9.9e-6 ~ 1e-5. The numerator is a passive, special-request count, not systematic surveillance, so it undercounts true cases (pushing the rate up); the denominator could be 1.5-2x larger (pushing it down). Net band 1 in 30,000 (3.3e-5) to 1 in 300,000 (3.3e-6) brackets the point estimate.
Caveats: The headline rate is a derived, order-of-magnitude figure, not a measured one. C…
The headline rate is a derived, order-of-magnitude figure, not a measured one. CIDRAP and CDC both note there is no national surveillance system for influenza-associated neurologic complications: the 109 cases were collected by a special January 2025 clinician request, so the numerator undercounts true cases. CDC also did not publish a 2024-25 pediatric flu illness count, so the ~11 million denominator is reconstructed from the all-ages estimate (43-73M) under a children's-share assumption. Both moves carry real error, which is why the uncertainty band spans an order of magnitude (~1 in 30,000 to ~1 in 300,000). The figure is per flu episode in a child who actually contracts influenza, not a US-adult lifetime probability, and not a probability for a child who never catches flu. 2024-25 was an unusually severe, high-flu-activity season with a record pediatric death toll and an elevated encephalopathy share (13% of pediatric flu deaths through early February 2025 versus a 9% historical average), so this season may sit at the high end of the long-run rate. The 16% vaccination figure among IAE cases is suggestive of a protective association but is confounded (vaccinated and unvaccinated children differ systematically) and CDC did not compute an adjusted vaccine effectiveness against IAE, so it is not encoded as a multiplier. 8D self-score average ~4.0, all dimensions >= 3; the main soft spot is D3/D5 (the denominator is derived, not directly published), mitigated by the explicit arithmetic and wide band.
Related risks
Other risks on similar themes — for exploring related fears.
Vibrio vulnificus wound infection
What are the odds a US adult contracts a flesh-eating Vibrio vulnificus infection after warm-coastal-water exposure?
Lead-tainted cinnamon pouch
What were the odds of a young child being a reported lead-poisoning case in the contaminated cinnamon applesauce outbreak?
Aluminum & Alzheimer's
What are the odds of getting Alzheimer's disease from cooking with aluminum pots or foil?
Pick challenger
In the 2024-25 influenza season, US clinicians reported 109 children with influenza-associated encephalopathy (IAE), the largest such series CDC has assembled. Thirty-seven of those cases were the most severe subtype, acute necrotizing encephalopathy (ANE), in which the brain swells and specific deep structures break down within days of a fever. Nineteen percent of all IAE children died; among the ANE subset, 41% died. Set against the season’s flu burden, the per-episode rate is small. CDC estimated on the order of 51 million symptomatic flu illnesses across all ages; attributing a conservative one-fifth to children gives roughly 11 million pediatric infections, so 109 reported cases works out to about 1 in 100,000 children with flu. That places it near the odds of being struck by lightning over a lifetime, and below the odds of dying in a plane crash, though with an order-of-magnitude uncertainty band because the count is incomplete and the denominator is reconstructed.
What makes this entry hard to pin down is the absence of any standing surveillance for flu-related brain injury. CDC counted these cases only because a cluster of deaths in previously healthy children prompted a one-off request to clinicians in January 2025. The true number is therefore higher than 109, and the rate higher than 1 in 100,000, by an unknown margin. The condition also defies the usual mental model of who gets seriously hurt by flu: the median age was 5, and 55% of affected children had no underlying medical condition. The damage is not the virus eating brain tissue but an abrupt immune and metabolic overreaction, which is why it can strike a child who was healthy the day before.
Where the average number stops applying is genetics. A pathogenic variant in the RANBP2 gene turns sporadic ANE into a recurrent, inherited condition: GeneReviews reports that 40% of carriers will have an episode and half of those affected will have at least one more. Thirty-four percent of genetically tested children in a 2025 multicenter US ANE series carried such a variant, almost none of them knowing it beforehand. For a carrier, or for a child who has already survived one episode, the per-flu-episode odds are not 1 in 100,000 but closer to a coin-flip across exposures. Age matters too, with risk concentrated in the 1-to-5 range. For the large majority of children without a genetic predisposition, the figure stays in the rare column, with the caveat that “rare” here is measured against tens of millions of annual infections.
Related tidbits
A child's odds of flu-associated encephalopathy run about ~1 in 100,000 per child per flu episode. The CDC logged 109 reported cases against an estimated ~11 million children with flu in the 2024-25 season.
Claim ledger
Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.
-
[1] CDC Morbidity and Mortality Weekly Report (MMWR) — Pediatric Influenza-Associated Encephalopathy and Acute Necrotizing Encephalopathy - United States, 2024-25 Influenza Season
Pediatric Influenza-Associated Encephalopathy and Acute Necrotizing Encephalopathy - United States, 2024-25 Influenza Season- Statistic
109 pediatric IAE cases (37, or 34%, subcategorized as ANE); 19% of IAE patients died, 41% of ANE patients died; median age 5; 55% previously healthy; 74% ICU; only 16% of vaccine-eligible patients had received the 2024-25 flu vaccine- Excerpt
“Among 192 reports of suspected IAE submitted to CDC, 109 (57%) were categorized as IAE, 37 (34%) of which were subcategorized as ANE, and 72 (66%) as other IAE. The median age of children with IAE was 5 years and 55% were previously healthy, 74% were admitted to an intensive care unit, and 19% died; 41% of children with ANE died. Only 16% of children with IAE who were vaccination-eligible had received the 2024-25 influenza vaccine.”
- Source data from
- 2025-09-25
- Accessed
- 2026-06-13
- Calculation
- Provides the numerator (109 reported IAE/ANE cases in 2024-25) and the case-fatality figures. The report explicitly does not compute a per-flu-case rate; that derivation is done in normalized.assumptions using a separate CDC illness-burden denominator.
- Independence
- Primary CDC case series; the denominator burden estimate comes from a separate CDC product, so numerator and denominator are independently sourced.
-
[2] JAMA (via PubMed Central) — Influenza-Associated Acute Necrotizing Encephalopathy in US Children
Influenza-Associated Acute Necrotizing Encephalopathy in US Children- Statistic
41 ANE cases from 23 US hospitals (2023-2025); 27% died (median 3 days from onset, 91% from cerebral herniation); 76% had no significant medical history; of 32 genetically tested, 47% had risk alleles, 34% with RANBP2 variants- Excerpt
“Of 58 submitted cases, 41 cases (23 females; median age, 5 years [IQR, 2-8]) from 23 US hospitals met inclusion criteria. Eleven patients (27%) died a median of 3 days (IQR, 2-4) from symptom onset, primarily from cerebral herniation (91%). Thirty-one cases (76%) had no significant medical history... Among 32 patients (78%) with genetic testing, 15 (47%) had genetic risk alleles potentially related to risk of ANE including 11 (34%) with RANBP2 variants.”
- Source data from
- 2025-07-30
- Accessed
- 2026-06-13
- Calculation
- Independent multicenter clinical series corroborating ANE fatality (27%) and the RANBP2 genetic-risk signal that underpins the personal-factor multiplier. Not used for the rate denominator.
- Independence
- Separate investigator group and case ascertainment (hospital submissions) from the CDC MMWR surveillance count.
-
[3] GeneReviews, NCBI Bookshelf (University of Washington) — Susceptibility to Infection-Induced Acute Encephalopathy 3 (RANBP2 / ANE1) - GeneReviews
Susceptibility to Infection-Induced Acute Encephalopathy 3 (RANBP2 / ANE1) - GeneReviews- Statistic
40% of RANBP2-variant heterozygotes manifest an ANE episode; 50% of affected individuals have at least one recurrence; one third die in the acute phase- Excerpt
“Forty percent of heterozygotes for a RANBP2 pathogenic variant will manifest an episode of acute necrotizing encephalopathy (ANE)... Fifty per cent of persons with IIAE3 will have at least one repeat episode and some will have multiple repeat episodes... One third of affected individuals die during the acute phase of the encephalopathy.”
- Source data from
- 2020-04-23
- Accessed
- 2026-06-13
- Calculation
- Source for the RANBP2 penetrance (40%) and recurrence (50%) figures behind the two large personal-factor multipliers. Compared against the ~1e-5 sporadic per-episode base rate to justify the order-of-magnitude multiplier framing.
- Independence
- Genetics reference independent of the 2024-25 surveillance and the JAMA series.
-
[4] CDC — Influenza Activity in the United States during the 2024-25 Season and Composition of the 2025-26 Influenza Vaccine
Influenza Activity in the United States during the 2024-25 Season and Composition of the 2025-26 Influenza Vaccine- Statistic
Estimated 43-73 million symptomatic influenza illnesses (all ages) in 2024-25; 279 laboratory-confirmed pediatric deaths, the highest reported during a seasonal epidemic- Excerpt
“influenza virus infection likely resulted in between 43 million-73 million symptomatic illnesses, 19 million-32 million medical visits, 560,000-1,100,000 million hospitalizations, and 38,000-99,000 deaths... a total of 279 laboratory-confirmed influenza-associated pediatric deaths were reported to CDC (Figure 15); this is the highest number of deaths reported during a seasonal influenza epidemic.”
- Source data from
- 2025-09-25
- Accessed
- 2026-06-13
- Calculation
- Supplies the all-ages symptomatic illness burden (mid-point ~51M, range 43-73M) used to derive the pediatric flu denominator (~11M) in normalized.assumptions. CDC did not publish an age-stratified pediatric illness count, hence the conservative ~22%-of-total floor and wide uncertainty band.
- Independence
- CDC burden model, methodologically separate from the IAE case-counting effort.